|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heist RS and Engelman JA: SnapShot:
Non-small cell lung cancer. Cancer Cell. 21:448.e22012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Soroosh P and Doherty TA: Th9 and allergic
disease. Immunology. 127:450–458. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tete S, Saggini A, Maccauro G, Rosati M,
Conti F, Cianchetti E, Tripodi D, Toniato E, Fulcheri M, Salini V,
et al: Interleukin-9 and mast cells. J Biol Regul Homeost Agents.
26:319–326. 2012.PubMed/NCBI
|
|
6
|
Knoops L and Renauld JC: IL-9 and its
receptor: From signal transduction to tumorigenesis. Growth
Factors. 22:207–215. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen N, Lu K, Li P, Lv X and Wang X:
Overexpression of IL-9 induced by STAT6 activation promotes the
pathogenesis of chronic lymphocytic leukemia. Int J Clin Exp
Pathol. 7:2319–2323. 2014.PubMed/NCBI
|
|
8
|
Zhang J, Wang WD, Geng QR, Wang L, Chen
XQ, Liu CC and Lv Y: Serum levels of interleukin-9 correlate with
negative prognostic factors in extranodal NK/T-cell lymphoma. PLoS
One. 9:e946372014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Redell MS, Ruiz MJ, Alonzo TA, Gerbing RB
and Tweardy DJ: Stat3 signaling in acute myeloid leukemia:
Ligand-dependent and -independent activation and induction of
apoptosis by a novel small-molecule Stat3 inhibitor. Blood.
117:5701–5709. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He Y, Yang Y, Xu J, Liao Y, Liu L, Deng L
and Xiong X: IL22 drives cutaneous melanoma cell proliferation,
migration and invasion through activation of miR-181/STAT3/AKT
axis. J Cancer. 11:2679–2687. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng S, Liu Q, Liu T, Yang L, Zhang Q,
Shen T, Zhang X, Han X and Lu X: NME4 modulates PD-L1 expression
via the STAT3 signaling pathway in squamous cell carcinoma. Biochem
Biophys Res Commun. S0006-291X(30535-0)2020.[Epub ahead of
print].
|
|
12
|
Qu Y, He Y, Yang Y, Li S, An W, Li Z, Wang
X, Han Z and Qin L: ALDH3A1 acts as a prognostic biomarker and
inhibits the epithelial mesenchymal transition of oral squamous
cell carcinoma through IL-6/STAT3 signaling pathway. J Cancer.
11:2621–2631. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fionda C, Malgarini G, Soriani A, Zingoni
A, Cecere F, Iannitto ML, Ricciardi MR, Federico V, Petrucci MT,
Santoni A and Cippitelli M: Inhibition of glycogen synthase
kinase-3 increases NKG2D ligand MICA expression and sensitivity to
NK cell-mediated cytotoxicity in multiple myeloma cells: Role of
STAT3. J Immunol. 190:6662–6672. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li W, Jia G, Qu Y, Du Q and Liu B and Liu
B: Long non-coding RNA (LncRNA) HOXA11-AS promotes breast cancer
invasion and metastasis by regulating epithelial-mesenchymal
transition. Med Sci Monit. 23:3393–3403. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao M, Ang L, Huang J and Wang J:
MicroRNAs regulate the epithelial-mesenchymal transition and
influence breast cancer invasion and metastasis. Tumour Biol.
39:10104283176916822017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Banyard J and Bielenberg DR: The role of
EMT and MET in cancer dissemination. Connect Tissue Res.
56:403–413. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma J, Chen X, Xin G and Li X: Chronic
exposure to the ionic liquid [C8mim]Br induces
inflammation in silver carp spleen: Involvement of oxidative
stress-mediated p38MAPK/NF-κB signalling and microRNAs. Fish
Shellfish Immunol. 84:627–638. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou YW, Zhang H, Duan CJ, Gao Y, Cheng
YD, He D, Li R and Zhang CF: miR-675-5p enhances tumorigenesis and
metastasis of esophageal squamous cell carcinoma by targeting
REPS2. Oncotarget. 7:30730–30747. 2016.PubMed/NCBI
|
|
21
|
Wen J, Hu Y, Liu Q, Ling Y, Zhang S, Luo
K, Xie X, Fu J and Yang H: miR-424 coordinates multilayered
regulation of cell cycle progression to promote esophageal squamous
cell carcinoma cell proliferation. EBioMedicine. 37:110–124. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang RM, Xiao S, Lei X, Yang H, Fang F
and Yang LY: miRNA-487a promotes proliferation and metastasis in
hepatocellular carcinoma. Clin Cancer Res. 23:2593–2604. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song H, Li D, Wu T, Xie D, Hua K, Hu J,
Deng X, Ji C, Deng Y and Fang L: MicroRNA-301b promotes cell
proliferation and apoptosis resistance in triple-negative breast
cancer by targeting CYLD. BMB Rep. 51:602–607. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu C, Zheng H, Xie L and Zhang J:
Decreased miR-208 induced ischemia myocardial and reperfusion
injury by targeting p21. Pharmazie. 71:719–723. 2016.PubMed/NCBI
|
|
25
|
Yan X, Liu J, Wu H, Liu Y, Zheng S, Zhang
C and Yang C: Impact of miR-208 and its target gene nemo-like
kinase on the protective effect of ginsenoside Rb1 in
hypoxia/ischemia injuried cardiomyocytes. Cell Physiol Biochem.
39:1187–1195. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kakimoto Y, Tanaka M, Kamiguchi H, Hayashi
H, Ochiai E and Osawa M: MicroRNA deep sequencing reveals
chamber-specific miR-208 family expression patterns in the human
heart. Int J Cardiol. 211:43–48. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou C, Cui Q, Su G, Guo X, Liu X and
Zhang J: MicroRNA-208b alleviates post-infarction myocardial
fibrosis in a rat model by inhibiting GATA4. Med Sci Monit.
22:1808–1816. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cai B, Pan Z and Lu Y: The roles of
microRNAs in heart diseases: A novel important regulator. Curr Med
Chem. 17:407–411. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han M, Toli J and Abdellatif M: MicroRNAs
in the cardiovascular system. Curr Opin Cardiol. 26:181–189. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Malizia AP and Wang DZ: MicroRNAs in
cardiomyocyte development. Wiley Interdiscip Rev Syst Biol Med.
3:183–190. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Montgomery RL, Hullinger TG, Semus HM,
Dickinson BA, Seto AG, Lynch JM, Stack C, Latimer PA, Olson EN and
van Rooij E: Therapeutic inhibition of miR-208a improves cardiac
function and survival during heart failure. Circulation.
124:1537–1547. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
He D, Wang J, Zhang C, Shan B, Deng X, Li
B, Zhou Y, Chen W, Hong J, Gao Y, et al: Down-regulation of
miR-675-5p contributes to tumor progression and development by
targeting pro-tumorigenic GPR55 in non-small cell lung cancer. Mol
Cancer. 14:732015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen W, Wang J, Liu S, Wang S, Cheng Y,
Zhou W, Duan C and Zhang C: MicroRNA-361-3p suppresses tumor cell
proliferation and metastasis by directly targeting SH2B1 in NSCLC.
J Exp Clin Cancer Res. 35:762016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
An X, Ge J, Guo H, Mi H, Zhou J, Liu Y,
Weiyue and Wu Z: Overexpression of miR-4286 is an unfavorable
prognostic marker in individuals with non-small cell lung cancer. J
Cell Biochem. 120:17573–17583. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dai FQ, Li CR, Fan XQ, Tan L, Wang RT and
Jin H: miR-150-5p inhibits non-small-cell lung cancer metastasis
and recurrence by targeting HMGA2 and β-catenin signaling. Mol Ther
Nucleic Acids. 16:675–685. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tan X, Jiang L, Wu X, Feng W and Lin Q:
MicroRNA-625 inhibits the progression of non-small cell lung cancer
by directly targeting HOXB5 and deactivating the Wnt/β-catenin
pathway. Int J Mol Med. 44:346–356. 2019.PubMed/NCBI
|
|
38
|
Yang Y, Li H, Liu Y, Chi C, Ni J and Lin
X: miR-4319 hinders YAP expression to restrain non-small cell lung
cancer growth through regulation of LIN28-mediated RFX5 stability.
Biomed Pharmacother. 115:1089562019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hornakova T, Staerk J, Royer Y, Flex E,
Tartaglia M, Constantinescu SN, Knoops L and Renauld JC: Acute
lymphoblastic leukemia-associated JAK1 mutants activate the Janus
kinase/STAT pathway via interleukin-9 receptor alpha homodimers. J
Biol Chem. 284:6773–6781. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen N, Feng L, Qu H, Lu K, Li P, Lv X and
Wang X: Overexpression of IL-9 induced by STAT3 phosphorylation is
mediated by miR-155 and miR-21 in chronic lymphocytic leukemia.
Oncol Rep. 39:3064–3072. 2018.PubMed/NCBI
|
|
41
|
Pérez C, Mondéjar R, García-Díaz N,
Cereceda L, León A, Montes S, Durán Vian C, Pérez Paredes MG,
González-Morán A, Alegre de Miguel V, et al: Advanced-stage mycosis
fungoides. Role of the signal transducer and activator of
transcription 3, nuclear factor-κB and nuclear factor of activated
T cells pathways. Br J Dermatol. 182:147–155. 2020.PubMed/NCBI
|
|
42
|
Qin JJ, Yan L, Zhang J and Zhang WD: STAT3
as a potential therapeutic target in triple negative breast cancer:
A systematic review. J Exp Clin Cancer Res. 38:1952019. View Article : Google Scholar : PubMed/NCBI
|
